Back

Valve-in-valve TAVI regardless of risk profile - Discussion

2 September 2019 (15:31 - 15:40)
Organised by:
Congress Presentation Part of: Controversies in the treatment of aortic valve disease Treatment ESC Premium Access ESC Congress 2019

5 More presentations in this session

Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - PRO
Professor T. Folliguet (Creteil, FR)
Slides Video
Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - CON
Doctor R. Makkar (Los Angeles, US)
Slides Video
Presentation thumbnail
Pure aortic regurgitation remains off-limits for TAVI - Discussion
Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - PRO
Doctor D. Dvir (Jerusalem, IL)
Slides Video
Presentation thumbnail
Valve-in-valve TAVI regardless of risk profile - CON
Professor G. Gerosa (Padua, IT)
Slides Video

Access the full session

Session thumbnail
Controversies in the treatment of aortic valve disease

The Event

Event poster

ESC Congress 2019

2 September 2019 15:31 CET
You may be interested in
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
Congress Presentation
Valve-in-valve procedure for bioprosthesis dysfunction in rheumatic patients: a new procedure for an old disease
27 August 2021
thumbnail
Webinar
The EAPCI Journal Club: NOTION-2 trial
29 May 2024
thumbnail
Congress Presentation
Sutures or not, it can be fixed... Greece's first-ever valve in valve TAVI of a supra-annular transcatheter valve replacing a sutureless, bioprosthetic surgical one in aortic position
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources